Hopkins Researchers Develop Under-The-Skin Implant For Pain Treatment

July 25, 1996

Researchers at the Johns Hopkins Oncology Center have developed the first under-the-skin narcotic drug implant for the treatment of pain in cancer patients. The researchers believe that the polymer implant could offer an alternative to external drug delivery systems used to treat serious pain and may be a potential technique for the management of drug addiction.

The button-sized polymer works much like the continuous-release birth control implant. It will be inserted under the skin through a tiny incision made under mild, local anesthetic. The polymer contains a highly concentrated powder form of the commonly used narcotic drug hydromorphone. The drug is released in a steady amount into the bloodstream over one to three months.

The shape and size of the polymer, which is made at Hopkins, controls the release of pain medication. "Different polymers will be available to meet the needs of a particular patient, so that patients requiring more pain control can get polymers that release more drug, and those with very stable requirements for pain medications can get one that lasts longer," says Stuart Grossman, M.D., associate professor of oncology and director of the Center's cancer pain program.

Results of safety tests of the polymer in animals are reported in the July 1996, issue of Pain, and human trials should begin within a year, he said.

Grossman and his team began developing the pain polymer five years ago as an inexpensive, abuse-resistant way of offering pain management to people in developing nations, where cancer rates are high, but little or no treatment for pain is available.

"India produces 80 percent of the world's opiates, yet only a minuscule amount of oral morphine was prescribed to cancer patients last year," says Grossman. "Because of limited financial resources as well as widespread concern about uncontrolled use of narcotics, governments in developing countries historically have limited the availability of narcotics for the management of pain." Grossman says physicians in India seem eager to offer patients the polymer, which can be easily implanted before patients return to their villages. Villagers, many of whom cannot read or write and do not own clocks, will not need to store medicines or remember when and how to take them. The new drug delivery system is also appealing to Indian physicians because it reduces concerns about illegal sales of these drugs.

Following the successful completion of U.S. trials, the researchers hope to make the polymer available to cancer centers in developing nations for further study.

If the pain treatment trials prove effective, Grossman also expects the implant could be used as an alternative to oral methadone treatment for heroin and morphine addicts in the United States. Current addiction therapy requires daily visits to a clinic for an oral dose of methadone, which occupies opiate receptors in the brain and eliminates narcotic craving and withdrawal symptoms.

"In essence, these people become addicted to the clinic. They cannot travel or seek employment that would require them to be away from the clinic," says Deborah J. Rhodes, M.D., Robert Wood Johnson Fellow at Johns Hopkins and participant in this research. She believes the polymer could be a more effective and less costly method of treating patients who have been maintained successfully on methadone for several years.

Currently, Grossman says, 117,000 people are enrolled in federally funded methadone management programs at an annual cost to the taxpayer of $4,500 per person.

In addition to Grossman and Rhodes, other participants in this research are Glenn J. Lesser, M.D., Kam W. Leong, Ph.D., Hungnan Lo, Ph.D., and Susan L. Eller.
-end-


Johns Hopkins Medicine

Related Pain Articles from Brightsurf:

Pain researchers get a common language to describe pain
Pain researchers around the world have agreed to classify pain in the mouth, jaw and face according to the same system.

It's not just a pain in the head -- facial pain can be a symptom of headaches too
A new study finds that up to 10% of people with headaches also have facial pain.

New opioid speeds up recovery without increasing pain sensitivity or risk of chronic pain
A new type of non-addictive opioid developed by researchers at Tulane University and the Southeast Louisiana Veterans Health Care System accelerates recovery time from pain compared to morphine without increasing pain sensitivity, according to a new study published in the Journal of Neuroinflammation.

The insular cortex processes pain and drives learning from pain
Neuroscientists at EPFL have discovered an area of the brain, the insular cortex, that processes painful experiences and thereby drives learning from aversive events.

Pain, pain go away: new tools improve students' experience of school-based vaccines
Researchers at the University of Toronto and The Hospital for Sick Children (SickKids) have teamed up with educators, public health practitioners and grade seven students in Ontario to develop and implement a new approach to delivering school-based vaccines that improves student experience.

Pain sensitization increases risk of persistent knee pain
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis (OA), according to a new study by researchers from the Université de Montréal (UdeM) School of Rehabilitation and Hôpital Maisonneuve Rosemont Research Centre (CRHMR) in collaboration with researchers at Boston University School of Medicine (BUSM).

Becoming more sensitive to pain increases the risk of knee pain not going away
A new study by researchers in Montreal and Boston looks at the role that pain plays in osteoarthritis, a disease that affects over 300 million adults worldwide.

Pain disruption therapy treats source of chronic back pain
People with treatment-resistant back pain may get significant and lasting relief with dorsal root ganglion (DRG) stimulation therapy, an innovative treatment that short-circuits pain, suggests a study presented at the ANESTHESIOLOGY® 2018 annual meeting.

Sugar pills relieve pain for chronic pain patients
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology.

Peripheral nerve block provides some with long-lasting pain relief for severe facial pain
A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia (TGN) may produce long-term pain relief.

Read More: Pain News and Pain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.